Effect of one weeks treatment with a GLP-1R Agonist on glycemia and HGP Diabetes, 53:1187;2004 Postprandial metabolism in T2DM with and without DPP-4 inhibition K Azuma, JCEM 2008 Islet cell response to hypoglycemia with and without DPP-4 inhibition Glucagon Vlda 47 ng/L Cntl 34 ng/L ISR Vlda -70 pmol/m2/min Cntl -62 pmol/m2/min PP Vlda 115 pmol/L Cntl 62 pmol/L B Ahren, JCEM 2009 Treatment with Exenatide does not impair the counterregulatory glucagon response Diabetes 53:2397;2004
During the first week of using semaglutide GLP-1, significant weight loss may not be immediately noticeable
The medication may help start the journey, but long-term success often depends on sustainable lifestyle changes
The FDA-approved oral formulation (Rybelsus for diabetes, Wegovy pill for weight loss) has been clinically validated but requires much higher doses than injectable versions
Weeks 12: 2 mg once weekly Weeks 36: 4 mg once weekly Weeks 710: 8 mg once weekly Week 11+: 12 mg once weekly (if tolerated) Fast escalation: Select cases, monitored closely This fast-escalation schedule is used only in specific situations where close supervision is available, such as in specialty clinics or structured clinical trial settings that follow strict safety protocols
The bupropion component can increase seizure risk, particularly in patients with eating disorders, head trauma, or alcohol withdrawal
